Annual Survey Shows Surge in Proton Therapy Treatment
Over the past four years, the number of proton therapy centers has doubled, and a growing number of patients are being treated for an increasing variety of cancers. A recently completed survey of proton therapy centers in the U.S., shows that the annual number of patients treated with proton therapy has increased significantly from when the survey was first launched in 2012. The number of patients treated in 2016 was 70% higher than the number of patients treated in the first survey completed in 2012. In that time, the number of centers offering proton therapy has more than doubled, reflecting the growing knowledge among patients and healthcare providers of the clinical benefits of proton therapy.
To read the entire press release, click here.
PCG Welcomes Provision CARES Proton Therapy Knoxville To Our Membership!
PCG welcomes Provision CARES Proton Therapy Knoxville to our membership!
Provision CARES Proton Therapy Knoxville opened its doors to patients on January 20th 2014. They are the 13th proton center in the United States, the second in the southeast, and the first in the state of Tennessee. We are thrilled to be working with a proton center recognized in the industry for innovative treatment protocols!
Click below to learn more about the center:
PCG Member Spotlight: Shaakir Hasan, DO, New York Proton Center
Dr. Shaakir Hasan is an attending radiation oncologist at New York Proton Center. He subspecializes in proton therapy for genitourinary (GU) and prostate cancers, lymphoma, and pediatric malignancies. He has authored over 50 peer-reviewed publications in the oncology space and has presented his research at multiple international conferences.
Dr. Hasan completed his undergraduate degree at University of Michigan and received his Doctor of Osteopathic Medicine from Nova Southeastern University in Fort Lauderdale, Florida, where he was awarded membership in the National Scholastic Honor Society. He completed his internship at Crozer Keystone in Philadelphia and his residency training in radiation oncology at Allegheny Health Network in Pittsburgh, Pennsylvania where he served as Chief Resident and received the RSNA Roentgen Resident Research Award.
His philosophy of care is to empower patients with the knowledge, confidence, and support required to confront their disease.
Click here for more information about New York Proton Center’s Care Team.
PCG Appoints Dr. Charles Simone as Chair of the PCG Executive Council
PCG is thrilled to announce that Charles Simone, MD, from the Maryland Proton Treatment Center, has been appointed as the Chairman of the PCG Executive Council. Dr. Simone currently serves as the chair of the PCG Lung Committee and will now also lead the Council’s efforts to provide oversight for all PCG committees, protocol development and approvals, clinical policies and procedures, and organizational strategy implementation. Congratulations Dr. Simone!
PCG Welcomes Mayo Clinic To Our Membership!
PCG welcomes Mayo Clinic to our membership!
Mayo Clinic’s existing proton center in Minnesota opened in 2015 and the new center in Arizona is scheduled to begin treating patients in Spring 2016 . We are thrilled to be working with the teams from both locations!
Click below to learn more about the centers:
PCG Member Spotlight: Carl Rossi, Jr., MD, Scripps Proton Therapy Center
Dr. Rossi is a board certified radiation oncologist, specializing in proton beam therapy, specifically for prostate cancers and lymphomas and serves as the medical director of Scripps Proton Therapy Center. Dr. Rossi previously served as chief of genito-urinary and lymphoma radiation oncology services at Loma Linda University Medical Center and also served as an associate professor of radiation oncology. During his tenure at Loma Linda, Dr. Rossi treated more than 9,000 prostate cancer patients with proton therapy. Dr. Rossi has published more than 20 peer-reviewed articles, as well as contributed chapters to definitive textbooks on radiation oncology. Dr. Rossi earned his medical degree from Loyola University Stritch School of Medicine in 1988 and did his internship and residency at Loma Linda University Medical Center in radiation oncology. Dr. Rossi currently serves as the PCG principal investigator for Scripps Proton Therapy Center and is a member of both the PCG Genito-Urinary and Lymphoma Disease Site Committees.